Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customized delivery of high-quality antigens ...

SUNNYVALE, Calif., Sept. 2, 2025 /PRNewswire/ -- Inflammatix, a pioneering host response diagnostics company, today announced the publication of analytical data in the Journal of Clinical Microbiology ...

Innova Engineered Plastics, formerly ThermoFab, announced today the acquisition of PolyCraft Tech, a specialty manufacturer of precision cast urethane enclosures and components based in San Diego, CA.

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...

Relationship coach Blessing CEO has come to the defence of her fiancé, IVD, after he was reportedly detained by the Lagos State Police at the airport while attempting to travel to Qatar. According to ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

The Televes Innova Boss mixes great reception with a cool retro vibe. It provided sensitive and stable reception of local channels in our tests and should be a good choice for anyone who cannot ...

A federal judge in Texas ruled that the FDA overstepped its authority when it issued its Final Rule: Medical Devices; Laboratory Developed Tests in May of last year, which said laboratory-developed ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Adaptive Biotechnologies Corporation announced that as of January 1, 2025, the new Medicare Clinical Laboratory Fee Schedule includes a payment rate of $2,007 for its clonoSEQ test used for assessing ...